Key facts
- It has raised $7.3M; the latest was Seed Round ($7.3M) in Oct 2025.
- Notable investors include Desjardins Capital de Risque, Genesys Capital, Sectoral Asset Management, Seido Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Antegrade Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Antegrade Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Antegrade Medical
Operator of a medical device company intended to provide one-time use procedural tools for structural interventional cardiologists. The target's medical instruments enable an antegrade approach to treating advanced and high-risk patients, enabling structural interventional cardiologists to perform procedures more efficiently.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Ownership
- Privately Held (backing)
Antegrade Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Antegrade Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Antegrade Medical in its N-PORT filings yet. We sweep new filings monthly.